Phenotype‐specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20‐year cohort study
British Journal of Haematology · 2026
DOI: 10.1111/bjh.70588 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift British Journal of Haematology, 2026. Verfasst von Ioanna Saougou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Neutropenia, Autoimmune Diseases. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Childhood autoimmune neutropenia (AIN) encompasses heterogeneous entities; phenotype‐specific immunological profiles and their relationship to infection outcomes remain incompletely defined. To characterise clinical, immunological and long‐term outcomes across distinct phenotypes of childhood AIN. We conducted a retrospective cohort study of 112 children with antibody‐confirmed AIN at a tertiary centre over 20 years. Patients were classified into three phenotypes: primary autoimmune neutropenia (pAIN), long‐lasting neutropenia (LL‐Np) and late‐onset neutropenia (LO‐Np). Outcomes included lymphocyte subsets, immunoglobulin levels, infection‐related hospitalisation rates and time to resolution. The cohort comprised 90 pAIN (80.4%), 10 LL‐Np (8.9%) and 12 LO‐Np (10.7%) patients. LO‐Np was characterised by higher neutrophil counts, marked leucopenia, multi‐lineage lymphopenia (CD3+, CD4+, CD19+), frequent antinuclear antibodies (ANA) positivity (50%) and associated autoimmune disease (25%). No infection‐related hospitalisations occurred in LO‐Np (0.00/100 person‐years [PY]; 95% confidence interval [CI] 0.00–2.30) versus 1.38/100 PY in pAIN and 5.58/100 PY in LL‐Np. Immunoglobulin levels were normal across all patients. Median time to resolution was 19, 67 and 59 months in pAIN, LL‐Np and LO‐Np respectively (both p < 0.001 vs. pAIN). Late‐onset AIN represents a distinct phenotype with systemic immune dysregulation and multi‐lineage lymphopenia, yet paradoxically absence of infection‐related hospitalisations, reflecting preserved humoral immunity. Phenotype‐based stratification may guide clinical monitoring and therapeutic decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, Greece.
- Department of Haematology, University Hospital of Heraklion, Heraklion, Greece.
- Haemopoiesis Research Laboratory, School of Medicine, University of Crete, Heraklion, Greece.
ORCID-Profile: Ioanna Saougou, Alexandros Makis
Zitieren
APA
Saougou, I., Kosmeri, C., Chaliasos, N., Mavroudi, I., Pontikoglou, C., & Makis, A. (2026). Phenotype‐specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20‐year cohort study. British Journal of Haematology. https://doi.org/10.1111/bjh.70588
Vancouver
Saougou I, Kosmeri C, Chaliasos N, Mavroudi I, Pontikoglou C, Makis A. Phenotype‐specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20‐year cohort study. British Journal of Haematology. 2026. doi:10.1111/bjh.70588
BibTeX
@article{Saougou2026,
author = {Saougou, Ioanna and Kosmeri, Chrysoula and Chaliasos, Nikolaos and Mavroudi, Irene and Pontikoglou, Charalampos and Makis, Alexandros},
title = {Phenotype‐specific immune profiles and outcomes in childhood autoimmune neutropenia: A 20‐year cohort study},
journal = {British Journal of Haematology},
year = {2026},
doi = {10.1111/bjh.70588}
}
EUVIMED